Amman: The third phase of a project supporting cancer treatment for Syrian refugees at the King Hussein Cancer Center (KHCC) in Jordan has concluded. The project was implemented with support from the King Salman Humanitarian Aid and Relief Center (KSRelief).
According to Jordan News Agency, KSRelief covered the treatment costs for more than 526 Syrian refugee patients in Jordan during the third phase. This initiative aimed to provide the beneficiaries with necessary medical care and support during their difficult circumstances, with total assistance exceeding $1 million.
Nisreen Qatamesh, KHCC Director General, expressed her gratitude, saying: "We extend our sincere thanks to the Kingdom of Saudi Arabia for its ongoing humanitarian support, which has given Syrian refugee cancer patients a real opportunity to receive treatment and continue their journey with determination and resolve." She noted that Saudi support, through KSRelief, has been a cornerstone in providing medical care to patients in need, embodying the highest ideals of solidarity and humanitarian benevolence.
For his part, Dr. Abdullah bin Saleh Al-Muallim, Director of KSRelief Health and Environmental Aid Department, said the partnership between the King Hussein Cancer Foundation and the Saudi center began in 2018 and has become a "pioneering model of joint humanitarian work." Under the agreement, he noted the total number of patients has reached 645 Syrian refugee cancer patients, who have received treatment across all stages of their illness. This effort, he stated, comes as part of the Kingdom of Saudi Arabia's efforts and the directives of its wise leadership to support Syrian brothers and sisters both inside and outside Syria.